Show simple item record

dc.contributor.authorHalpin, David M. G.
dc.contributor.authorKerkhof, Marjan
dc.contributor.authorSoriano, Joan B.
dc.contributor.authorMikkelsen, Helga
dc.contributor.authorPrice, David B.
dc.date.accessioned2016-10-03T12:00:10Z
dc.date.available2016-10-03T12:00:10Z
dc.date.issued2016-09-23
dc.identifier71318875
dc.identifierbc268e19-7c21-47f0-b893-53090d040d2b
dc.identifier27663386
dc.identifier84988603222
dc.identifier.citationHalpin , D M G , Kerkhof , M , Soriano , J B , Mikkelsen , H & Price , D B 2016 , ' Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy ' , Respiratory Research , vol. 17 , 120 , pp. 1-13 . https://doi.org/10.1186/s12931-016-0433-5en
dc.identifier.issn1465-9921
dc.identifier.urihttp://hdl.handle.net/2164/7564
dc.descriptionAcknowledgments The authors wish to acknowledge Derek Skinner with gratitude for his assistance with data extraction and analysis. Funding Data access and analyses were funded by Boehringer Ingelheim, who played no role in the conduct or reporting of the studyen
dc.format.extent13
dc.format.extent608831
dc.language.isoeng
dc.relation.ispartofRespiratory Researchen
dc.subjectrandomised controlled trialen
dc.subjectreal-life researchen
dc.subjectchronic obstructive pulmonary diseaseen
dc.subjectlong-acting bronchodilatorsen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleEligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doi10.1186/s12931-016-0433-5


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record